MiR-31-3p do not predict anti-EGFR efficacy in first-line therapy of RAS wild-type metastatic right-sided colon cancer

Autor:	Boisteau, Emeric, Lespagnol, Alexandra, De Tayrac, Marie, Corre, Sébastien, Perrot, Anthony, Rioux-Leclercq, Nathalie, Martin-Lannerée, Séverine, Artru, Pascal, Chalabreysse, Philippe, Poureau, Pierre-Guillaume, Doucet, Laurent, Coupez, Dahna, Bennouna, Jaafar, Bossard, Céline, Coriat, Romain, Beuvon, Frédéric, Bauguion, Lucile, Leclair, François, Chautard, Romain, Lecomte, Thierry, Guyetant, Serge, Desgrippes, Romain, Grasset, Denis, Lhostis, Hélène, Bouhier-Leporrier, Karine, Bibeau, Frédéric, Edeline, Julien, Galibert, Marie-Dominique, Lièvre, Astrid
Zdroj:	In Clinics and Research in Hepatology and Gastroenterology May 2022 46(5)
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect